- Home
- SBFM vs CELZ Comparison
SBFM vs CELZ Comparison
Compare SBFM & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- CELZ
- Stock Information
- Founded
- SBFM 2006
- CELZ 1998
- Country
- SBFM United States
- CELZ United States
- Employees
- SBFM N/A
- CELZ N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- CELZ Health Care
- Exchange
- SBFM Nasdaq
- CELZ Nasdaq
- Market Cap
- SBFM 4.3M
- CELZ 4.7M
- IPO Year
- SBFM N/A
- CELZ N/A
- Fundamental
- Price
- SBFM $2.84
- CELZ $3.31
- Analyst Decision
- SBFM
- CELZ
- Analyst Count
- SBFM 0
- CELZ 0
- Target Price
- SBFM N/A
- CELZ N/A
- AVG Volume (30 Days)
- SBFM 139.0K
- CELZ 9.2K
- Earning Date
- SBFM 08-16-2024
- CELZ 08-09-2024
- Dividend Yield
- SBFM N/A
- CELZ N/A
- EPS Growth
- SBFM N/A
- CELZ N/A
- EPS
- SBFM N/A
- CELZ N/A
- Revenue
- SBFM $30,481,982.00
- CELZ $17,000.00
- Revenue This Year
- SBFM $86.70
- CELZ N/A
- Revenue Next Year
- SBFM $126.76
- CELZ N/A
- P/E Ratio
- SBFM N/A
- CELZ N/A
- Revenue Growth
- SBFM 109.82
- CELZ N/A
- 52 Week Low
- SBFM $2.42
- CELZ $2.90
- 52 Week High
- SBFM $864.00
- CELZ $10.28
- Technical
- Relative Strength Index (RSI)
- SBFM 31.92
- CELZ 46.62
- Support Level
- SBFM $2.75
- CELZ $3.34
- Resistance Level
- SBFM $3.00
- CELZ $3.87
- Average True Range (ATR)
- SBFM 0.20
- CELZ 0.21
- MACD
- SBFM 0.19
- CELZ 0.02
- Stochastic Oscillator
- SBFM 23.17
- CELZ 27.27
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.